EvoNK·EvoStem COPD immune/regenerative treatment
Why is COPD regenerative management important?
Limitations of existing treatments and differences between LACELLIC
WHY LACELLIC HYBRID IS DIFFERENT?
EvoNK + EvoStem 24 sessions over 12 weeks
COPD immunity and regeneration core proposed by LACELLIC
LACELLIC COPD MEDICAL TOUR
LACELLIC Medical Tour Package Chronic Obstructive Pulmonary Disease (COPD) is known as a respiratory disease in which chronic inflammation of the airways and alveoli gradually narrows the passage of air in and out.
Changes in daily life are often felt first, such as shortness of breath when climbing stairs, coughing and phlegm in the morning, or shorter walking distances than before.
A frequently mentioned aspect of COPD is the direction of recovery. It has been reported that once destroyed alveoli and damaged airway mucosa are difficult to return naturally, apart from alleviating symptoms, how to manage the structure itself that leads to inflammation is also discussed.
However, an individual's condition cannot be judged based on these descriptions alone. Confirmation through pulmonary function tests (spirometry), chest imaging, and pulmonology specialist care should be given priority.
Methods that have been considered together so far
Bronchodilators and inhaled steroids are standard treatments for COPD, along with smoking cessation, respiratory rehabilitation, vaccination, and management of acute exacerbations.
These treatments play an important role in managing symptoms and reducing acute exacerbations and are at the discretion of your health care provider. On the one hand, it has been mentioned that these methods focus on widening the airways and alleviating surface inflammation, making it difficult to reach the alveolar tissue itself, which has already lost its function, or the immune signals that create chronic inflammation.
At this point, research is continuing on approaches that look at immune regulation and tissue regeneration together. An approach that views immunity and regeneration together — EvoNK · EvoStem
LACELLIC's cell platform has split roles.
• EvoNK—NK immune cell therapy. Acts as a shield for the immune system that recognizes and eliminates abnormal cells • EvoStem—Stem cell regeneration treatment using autologous cells. The center of regeneration that creates an environment for tissues to repair themselves • EvoX—a nano-signaling substance.
Helps communicate between cells and helps transplanted cells settle down
The reason why both platforms are used together in the management of COPD is because this disease has both the problem of subsequent inflammation and tissue damage. If you only deal with one side, the other side remains.
Here's where the hybrid configuration comes together in COPD management:
• Induces regeneration of damaged alveoli and airway mucosa • Regulates ongoing chronic inflammatory signals that narrow the airways • Aims to slow the rate of decline in lung function • Re-establishes balance in malfunctioning immune responses
EvoStem is designed to minimize immune rejection by utilizing the patient's own autologous cells and platelet technology.
This is not a program that focuses on pushing too hard, but rather maintains the current moment and continues the management time for a long time.
The program is planned as a combination of EvoNK and EvoStem administered 24 times over 12 weeks. These numbers represent the number of sessions of the program and do not represent treatment results.
However, for COPD, application and method vary depending on the stage (GOLD classification), lung function level, smoking history, frequency of acute exacerbations, concomitant diseases, and systemic condition.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
Also, please understand that this is not a concept of restoring lost lung function, but rather an approach aimed at controlling inflammation and maintaining remaining function for a long time.
The priority is to continue the inhalation treatment, smoking cessation, and respiratory rehabilitation currently in progress at the discretion of the medical staff in charge, and the cell program is not a replacement for this.
Do not stop treatment arbitrarily and be sure to consult your doctor. Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home, and connection with global partner networks in Southeast Asia, the Middle East, and the Americas are also provided.
The basic schedule is a one-time visit to Korea, from precise diagnosis to cell transplantation, and then repeated visit cycles and ongoing management based on the EvoX platform are reviewed.
The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation. As this is a disease in which long-distance travel and the in-flight environment can put a strain on breathing, we recommend that you plan your visit after checking your current breathing status and oxygen requirement.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
The 24 sessions over 12 weeks in this text are the number of program sessions and do not guarantee individual treatment results.
The scope of support for global partner network connections may vary depending on the partner organization and country, and may not be available in all regions. Progress and results may vary depending on the individual's condition.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
